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Buruli ulcer (BU) imposes a serious economic burden on affected households
and on health systems that are involved in diagnosing the disease and treating
patients. Research is needed to find cost-effective therapies for this costly
disease. Plants have always been an important source of new pharmacologically
active molecules. Consequently we decided to undertake the study of plants used
in traditional treatment of BU in Benin and investigate their antimycobacterial
activity as well as their chemical composition. Extracts from forty-four (44)
plant species were selected on account of reported traditional uses for the
treatment of BU in Benin and were assayed for antimycobacterial activities.
Crude hydroethanolic extract from aerial parts of Holarrhena floribunda (G. Don)
T. Durand and Schinz was found to have significant antimycobacterial activity
against M. ulcerans (MIC = 125 µg/mL). We describe here the identification of
four steroidal alkaloids from Mycobacterium ulcerans growth-...
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Buruli ulcer (BU) imposes a serious economic burden on affected households and on health systems that are involved in diagnosing
the disease and treating patients. Research is needed to find cost-effective therapies for this costly disease. Plants have always been
an important source of new pharmacologically active molecules. Consequently we decided to undertake the study of plants used
in traditional treatment of BU in Benin and investigate their antimycobacterial activity as well as their chemical composition.
Extracts from forty-four (44) plant species were selected on account of reported traditional uses for the treatment of BU in Benin
andwere assayed for antimycobacterial activities. Crude hydroethanolic extract from aerial parts ofHolarrhena floribunda (G.Don)
T. Durand and Schinz was found to have significant antimycobacterial activity againstM. ulcerans (MIC = 125𝜇g/mL).We describe
here the identification of four steroidal alkaloids fromMycobacterium ulcerans growth-inhibiting fractions of the alkaloidal extract
of the aerial parts ofHolarrhena floribunda. Holadysamine was purified in sufficient amount to allow the determination of its MCI
(=50𝜇g/mL). These results give some support to the use of this plant in traditional medicine.
1. Introduction
Buruli ulcer (BU), caused by the environmental organism
Mycobacterium ulcerans and characterized by necrotizing
skin and bone lesions, poses important public health issues as
the third most common mycobacterial infection in humans
[1]. The disease has become substantially more frequent over
the past decade, particularly around the Gulf of Guinea, and
has beendetected or suspected in at least 31 countries. Clinical
diagnosis of BU disease should be confirmed by PCR, as rec-
ommended by the World Health Organization (WHO), and
case patients should be treated with rifampin/streptomycin
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daily for 8 weeks (therapy available since 2004), combined, if
necessary, with surgery.
In Benin, sociocultural believes and practices strongly
influence the health-seeking behaviours of people affected by
BU. The first recourse is often traditional treatment. Most of
the components in the traditional treatment belong to the
plant kingdom [2]. Plants provide unlimited opportunities
for new drug leads because of the unmatched availability of
chemical diversity. Recently we carried out an ethnobotanical
survey involving seventeen traditional practitioners within
the Ouinhi community in the Zou Department (Benin). We
noted that about forty-nine different plants were used for the
traditional treatment of BU. Different parts of these plants
were included in various pharmaceutical forms for internal or
external use [2]. We realized a screening of 44 plant extracts
used in traditionalmedicine to treat BU [2, 3]. Results showed
that crude hydroethanolic extract of Holarrhena floribunda
was effective in inhibiting the growth of Mycobacterium
ulcerans (MIC 125𝜇g/mL) and worth further investigations.
Holarrhena floribunda (G. Don) T. Durand and Schinz
grows as a shrub or tree up to 25m tall, with a stem
diameter of up to 30 cm. Its fragrant flowers feature a white
corolla. Fruit is pale grey to dark brown with paired follicles,
each up to 60 cm long. This species is known as four syn-
onyms:Rondeletia floribundaG.Don,Holarrhena africanaA.
DC., Holarrhena wulfsbergii Stapf, Holarrhena ovata. In the
Republic of Benin, the common names of this plant are: Fon:
“kpakpatoun” [2]; Yoruba and Nago: “ako ire,” “ire Ibedji;”
Mina: “gaoti” [4]. Hoyer et al. [5] in 1978 isolated from the
bark of the trunk a steroidal alkaloid called holarrhesine, but
no activity was reported for this compound. They also iso-
lated conessine from the bark of the root. A chemical study of
the leaves ofH. floribunda achieved by Janot team in 1959 led
to the isolation of other new alkaloids including holaphylline
and holaphyllamine, while other alkaloids were isolated later.
Figure 1 shows the structures of the 9 chemical compounds
isolated from H. floribunda: holaphylline, holaphyllamine,
holamine, holaphyllinol, holaphyllidine, holadysamine, hol-
arrhesine, conessine, and progesterone [6–9]. Phytochemical
investigations on this plant have so far led to the identification
of a crude in vitro active alkaloid extract on M. tuberculosis
(MCI = 0.075 g/L) and other microorganisms [10, 11].
Here we describe compounds identified from bioactive
fractions of the extract and evaluation of the inhibitory effect
of one of them on the growth ofM. ulcerans.
2. Materials and Methods
2.1. Experimental
2.1.1. Plant Materials. Plant species was collected and iden-
tified by a botanist from the National Herbarium of Benin
and voucher specimens (Yemoa 06) are deposited at the same
herbarium.
2.1.2. Preparation of Crude Hydroethanolic Extracts. Dried
plants were ground to a powder with a pulverizator (National
Mixer Grinder Mx-119N, Japan). 50 g of powder was then
macerated 48 h (at room temperature) in 70% ethanol in a
1/10 (w/v) ratio.The material was filtered through a Millipore
filter of 0.2𝜇m(Acrodisc, USA).Thefiltrate was concentrated
under reduced pressure at less than 40∘C using a rotary
evaporator (Buchi Rotavapor R-200/205, Switzerland) to
obtain a crude residue.
2.1.3. Fractionation of Crude Extracts and Isolation of Active
Constituents. Crude hydroethanolic extract was fractionated
on silica gel 60 (0,063–0,200mmMerck, Germany) by atmo-
spheric pressure liquid chromatography eluting with solvents
of increasing polarity, namely, hexane, dichloromethane,
ethyl acetate, and water, yielding 4 fractions (F1, F2, F3, and
F4). Of these, fraction F2 (dichloromethane) was found
to cause growth inhibition of M. ulcerans and was, as a
result, selected for further work.This fraction was monitored
using TLC plates (TLC silica gel 60F
254S, Merck) and led
to characterize the presence of alkaloids (toluene : ethyl ace-
tate : diethylamine: [7 : 2 : 1], detection-Dragendorff ’s spray
reagent). We then performed a more specific extraction to
obtain an enriched alkaloid extract (Figure 2).
We therefore proceeded to fractionation of this enriched
extract by Atmospheric Pressure Liquid Chromatography
(APLC) and Medium Pressure Liquid Chromatography
(MPLC) followed by gel filtration on Sephadex LH20 to
purify this enriched alkaloid fraction.
Atmospheric Pressure Liquid Chromatography (APLC). Alka-
loids enriched extract was repeatedly fractionated on silica
gel 60 (0,063–0,200mm, Merck, Germany) eluting with
solvents of increasing polarity (mixture of CH
2
Cl
2
/MeOH
50 : 50 to 100% MeOH followed by MeOH :H
2
O 90 : 10 and
MeOH : acetic acid 90 : 10). Fractions weremonitored by TLC
(toluene : ethyl acetate : diethylamine : [7 : 2 : 1], detection-
Dragendorff ’s spray reagent) and similar fractions were
combined and concentrated in vacuo. Prepurified fractions
obtained by APLC were rechromatographied by MPLC.
Medium Pressure Liquid Chromatography (MPLC). MPLC
was performed on glass columns packed with LiChroprep Si
60 (15–25𝜇m) fromMerck with a mobile phase composed of
CH
2
Cl
2
/MeOH 50 : 50 to 100% MeOH. Prepurified fractions
obtained were monitored by TLC (toluene : ethyl acetate : di-
ethylamine: [7 : 2 : 1], detection-Dragendorff ’s spray reagent)
and similar fractions were combined and concentrated in
vacuo followed by gel filtration on Sephadex LH20 (MeOH).
Five different purified fractions were obtained and analyzed
by high pressure liquid chromatography coupled to mass
spectroscopy (HPLC-MS or LC-MS) (Thermo Scientific
Accela LC Systems, orbitrap).
LC-MS. High pressure liquid chromatography coupled to a
diode array detection and mass spectrometry with positive
electrospray ionization (HPLC-ESI-MSn) was employed to
rapidly separate and identify the constituents in these five
purified fractions. The LC MS/MS system consisted in a
Thermo Accela pump, autosampler, photodiode array detec-
tor, andThermo Scientific LTQ orbitrap XLmass spectrome-
ter.
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Figure 1: Structures of chemical compounds isolated from H. floribunda.
Hexane phase
Aqueous solution CH2Cl2 dried with Na2SO4
(total alkaloids)
Aqueous phase
(NaOH 10%)
Hexane (3 × 200mL)
CH2Cl2 (3 × 200mL)
Hydroethanolic extract
(acidified with H2SO4 2%)
Figure 2: Scheme for preparation of alkaloids enriched extract.
Separation was performed using an analytical RP-C18
Lichrospher-100 column (250 × 4mm, particle size 5𝜇m)
with a gradient using acetonitrile and 0, 05% trifluoroacetic
acid (TFA) aqueous solution as the mobile phase. The gradi-
ent used starts at 90% aqueous solution and 10% acetonitrile,
going to a plateau of 100% acetonitrile in 25min. These
conditions are held for 15min before returning to the initial
conditions. The gradient was linear and the flow rate was
0.4mL/min. The injection volume was 10 𝜇L; the column
temperature was 30∘C.
High-resolutionMS was measured with ESI source in the
positive mode. The following inlet conditions were applied:
capillary temperature 275∘C, capillary voltage 35V, tube lens
110V, sheath gas flow 8 u.a, auxiliary gas flow 0 u.a, and
sweep gas flow 0 u.a. Data acquisition and processing were
performed with Xcalibur software version 2.0.7.
NMR. NMR spectra (1H, 13C, 1H-1H COSY, and 1H-13C
HSQC) were recorded using a Bruker-300, 300MHz for 1H
and 75MHz for 13C. Chemical shifts were expressed in ppm
(𝛿) usingTMS (tetramethylsilane) (Aldrich Sigma,Germany)
as reference. For NMR analysis, the sample was dissolved
in 400 𝜇L of CDCl
3
-MeOD (2 : 1) and transferred to a NMR
tube.
3. Results and Discussion
Our previous investigations allowed determining that the
hydroethanolic extract of H. floribunda inhibited growth
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of M. ulcerans with a MIC value of 125𝜇g/mL using the
resazurin microtiter assay (REMA) [3]. The CH
2
Cl
2
fraction
of this extract also inhibited growth of M. ulcerans with a
MIC value of 125 𝜇g/mL and contained alkaloids. Fraction-
ation of an enriched alkaloid extract (MIC = 62.5𝜇g/mL)
was undertaken as described in the Experimental Section,
allowing the identification of four different alkaloids in five
different fractions and isolation of one of them with high
purity. The structure of the major compound was identified
as holadysamine (3-methyl amino pregna5,16-dien-20-ol) by
MS and NMR [8]. LC-MS was used to identify alkaloids in
the other fractions, named compounds A, B, and C, and
gave molecular formula of, respectively, C
22
H
37
ON (MW:
331.29), C
21
H
33
ON (MW: 315.26), and C
23
H
37
ON (MW:
343.29). According to bibliographic data on compounds
isolated from H. floribunda [7, 8], they could correspond
to holaphyllinol (MW: 331.29), holamine, or holaphyllamine
(MW: 315.26), N,N-dimethyl holamine, N-dimethyl hola-
phyllamine or methyl 6 holaphylline (MW: 343.29).
HPLC-ESI-MS/MS allowed us to show that compound
A could correspond to holaphyllinol and B to holamine or
holaphyllamine while C seems to be a new compound. On
the basis of the analysis of spectroscopic data, we observed
the presence of a fragment at m/z 326 ([M-H
2
O+H]+) and
the loss of a water molecule in the MS/MS fragmentations
of C allowing us to propose an alcoholic and not a ketonic
function on C20 (Figure 3).
Further studies must be performed to confirm these
chemical structures. It could not be done because of the lack
of compound.
Fraction containing pure holadysamine was found to be
more active (MIC = 50 𝜇g/mL) than fractions containing A,
B, or C or the crude hydroethanolic extract (125 𝜇g/mL) but
less active than the reference rifampicin (MIC = 2𝜇g/mL).
This low activity could not totally explain the use of this
plant in traditional treatment but as this plant is used in
mixtures with other plants; the various compounds present
in these plant extracts can act synergistically as it is the
case with the antibiotics ethambutol, clarithromycin, and
rifampicin [12]. Rastogi and Labrousse in their study showed
that the use of these antibiotics in combination results in
increased bactericidal effects compared to drugs used alone
or in combination with two of them.
4. Conclusions
Our results show that extracts of aerial parts ofH. floribunda,
used by traditional healers to treat BU, exhibited significant
in vitro antimycobacterial activities. Four active alkaloids
have been identified. Holadysamine the major compound
was found to be the most active one (MIC = 50 𝜇g/mL), but
this activity is lower than that of rifampicine. As synergy
may be found between different compounds, it would be
interesting to analyze the efficacy of the other alkaloids and
their combinations. Furthermore, as this plant is used in
association with other ones, it is also interesting to test plant
associations as used by traditional practitioners. Remedies
that would prove effective activity should be applied for
OH
N
Chemical formula: C23H37NO
Exact mass: 343.28751
Figure 3: Proposed chemical structure for compound C.
toxicological and pharmacological studies. There is also an
urgent need of standardization of traditional remedies based
on plants.
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